Abstract

Deficiencies in DNA repair and DNA degrading nucleases can lead to accumulation of cytosolic DNA and the activation of STING pathways in tumor cells. The DNA sensors that recognize cytosolic DNA in tumor cells are not known. Here we show that double-stranded DNA and RNA:DNA hybrids bind cGAS and activate the cGAS-STING pathway in TRAMP-C2 prostate and other cancer cells. STING function in TRAMP-C2 cells was critical for rejection and immune cell infiltration of TRAMP-C2 tumors. In contrast, STING agonists failed to active STING and induce type I interferon (IFN) expression in many tested tumor cells. Inhibition of JAK2 and STAT3 restored type I IFN expression in these tumor cells. Intratumoral injections of IL-6, a known activator of JAK2 and STAT3, significantly reduced the anti-tumor effects of cGAMP. In summary, we show that IL-6 suppresses recognition of cytosolic DNA by the cGAS-STING pathway in tumor cells, which contributes to anti-tumor responses. Funding Statement: This work was supported by the NRF grant HUJ-CREATE-Cellular and Molecular Mechanisms of Inflammation and a ministry of education grant. Declaration of Interests: The authors declare no potential conflicts of interest. Ethics Approval Statement: Mice were housed according to the IACUC guidelines of the National University of Singapore (R14-0204).

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.